Skip to main content
Caplight Logo









Imeka

Imeka

Private
SherbrookeHealthcare & Life Scienceshttps://imeka.ca/

Last Round

Grant

Oct 24, 2023

Total Funding Raised

$1.79M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Imeka is a healthtech company that provides AI-powered medical imaging software to analyze brain white matter connectivity for clinical and pharmaceutical research applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Clinical Trials, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

neuroimagingwhite matter analysisdiffusion MRIsoftware as a medical deviceSaMDimaging biomarkersmedical AIclinical trial supporttractographyneurodegenerative disease researchdigital biomarkersAI-powered diagnosticsmedical image analysisbiotech analyticsclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Imeka Comparables

Compare Imeka with similar companies based on industry and business-model similarity.

Imeka comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qynapse
82%
Biospective Inc.
79%
IXICO plc
78%

Imeka Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 24, 2023
DebtJul 25, 2023
SeedDec 14, 2017

Key People

Founding team and executive leadership

Jean-René Bélanger

CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 39% MoM.

  • May 15, 2026

    Monthly visitors grew 149% MoM.

Imeka Filings

Explore SEC and related filing metadata, where available.

Imeka filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Imeka's valuation, stock price, and market status.

Is Imeka a public or private company?

Imeka is a private company.

What is the current stock price of Imeka?

Imeka is a private company with no public stock price. No recent secondary market data is available.

How much is Imeka worth (valuation)?

Valuation information for Imeka is not publicly available.

Can I buy Imeka stock?

Imeka shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Imeka's last funding round?

Imeka's most recent funding round was Grant on October 24, 2023.

Who are the main investors in Imeka?

Key investors in Imeka include Hacking Health Accelerator, Creative Destruction Lab, Desjardins Capital, Canada Economic Development for Quebec Regions, Sherbrooke Innopole.

Will Imeka IPO soon?

No public IPO plans have been announced for Imeka.

How can I track Imeka secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Imeka's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSherbrooke
Employee Range23
Year Founded2011
Last FundingOct 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?